LIPODYSTROPHY
Clinical trials for LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug access for rare leptin disorders
Disease control AVAILABLEThis expanded access program provides REGN4461 to patients with lipodystrophy or monogenic obesity caused by deficient leptin signaling. The goal is to offer treatment to those who have no other options. Participants receive the drug under close medical supervision.
Matched conditions: LIPODYSTROPHY
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New study investigates pregnancy risks for women on rare fat disorder drug
Knowledge-focused Recruiting nowThis study looks at women with lipodystrophy, a condition where the body lacks fat tissue, and how taking the drug metreleptin during pregnancy affects both mother and child. Researchers will compare pregnancy outcomes between women who took the drug and those who did not. The go…
Matched conditions: LIPODYSTROPHY
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated May 17, 2026 04:14 UTC
-
Scientists dive deep into fat storage mystery
Knowledge-focused Recruiting nowThis study aims to understand how fat is stored in people with familial partial lipodystrophy (FPLD), a condition that leads to serious health issues like diabetes and heart disease. Researchers will compare fat tissue samples from 14 participants (some with FPLD, some healthy) a…
Matched conditions: LIPODYSTROPHY
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC